Anxiety induced by repetitive transcranial magnetic stimulation is suppressed by chronic treatment of paroxetine in rats

Pharmacopsychiatry

Volumn 36, Issue 1, 2003, Pages 7-11

  Isogawa, K ^a   Fujiki, M ^a   Akiyoshi, Jotaro ^a   Tsutsumi, T ^a   Horinouchi, Y ^a   Kodama, K ^a   Nagayama, H ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

Anxiety; Chronic treatment; Paroxetine; Rats; Serotonin; Transcranial magnetic stimulation

Indexed keywords

FLUOXETINE; FLUVOXAMINE; PAROXETINE; SERTRALINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY DISORDER; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; LOCOMOTION; LONG TERM CARE; MALE; MOOD DISORDER; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONINERGIC SYSTEM; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT OUTCOME;

ACUTE DISEASE; ANIMALS; ANXIETY; CHRONIC DISEASE; ELECTRIC STIMULATION; FEAR; MALE; MAZE LEARNING; MOTOR ACTIVITY; PAROXETINE; RATS; RATS, WISTAR; SEROTONIN UPTAKE INHIBITORS; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 0345505658     PISSN: 01763679     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-38085     Document Type: Article

References (24)

1. Baldwin D, Bobes J, stein DJ, Scharwachter I, Faure M. Paroxetine in social phobia/social anxiety disorder. Randomized, double-blind, placebo-controlled study. Paroxetine Study Group. Br J Psychiatry 1999; 175: 120-126
2. Barker AT. An introduction to the basic principles of magnetic nerve stimulation. J Clin Neurophysiology 1991; 8: 26-37
3. Belmaker RH, Fleischmann A. Transcranial magnetic stimulation: a potential new frontier in psychiatry. Biol Psychiatry 1995; 38: 419-421
4. Ben-Shachar D, Gazawi H, Riboyad-Levin J, Klein E. Chronic repetitive transcranial magnetic stimulation alters beta-adrenergic and 5-HT2 receptor characteristics in rat brain. Brain Res 1999; 816: 78-83
5. Feinsod M, Kreinin B, Chistyakov A, Klein E. Preliminary evidence for a beneficial effect of low-frequency, repetitive transcranial magnetic stimulation in patients with major depression and schizophrenia. Depress Anxiety 1998; 7: 65-68
6. Fujiki M, Steward O. High frequency transcranial magnetic stimulation mimics the effect of ECS in upregulating astoglial gene expression in the murine CNS. Mol Brain Res 1997; 44: 301-308
7. Gates JR. Transcranial magnetic stimulation. Neuroimaging Clin N Am 1995; 5: 711-720
8. George MS, Wassermann EM, Williams WA, Callahan A, Ketter TA, Basser P, Hallett M, Post RM. Daily repetitive transcranial magnetic stimulation (rTMS) improves mood in depression. Neuroreport 1995; 6: 1853-1856
9. George MS, Wassermann EM, Post RM. Transcranial magnetic stimulation: a neuropsychiatric tool for the 21st century. J Neuropsychiatry Clin Neurosci 1996; 8: 373-382
10. George MS, Ketter TA, Kimbrell TA, Speer AM,Lorberbaum J, Liberaatos CC, Nahas Z, Post RM. Neuroimaging approaches to the study of emotion. In Borod JC, editor. The Neuropsychogy of Emotion, New York: 2000: 123-124
11. Greenberg BD, George MS, Martin JD, Benjamin J, Schlaepfer TE, Altemus M, Wassermann EM, Post RM, Murphy DL. Effect of prefrontal repetitive transcranial magnetic stimulation in obsessive-compulsive disorder: a preliminary study. Am J Psychiatry 1997; 154: 867-869
12. Grisaru N, Chudakov B, Yaroslavsky Y, Belmaker RH. Transcranial magnetic stimulation in mania: a controlled study. Am J Psychiatry 1998; 155: 1608-1610
13. Hausmann A, Weis C, Marksteiner J, Hinterhuber H, Humpel C. Chronic repetitive transcranial magnetic stimulation enhances c-fos in the parietal cortex and hippocampus. Mol Brain Res 2000; 76: 355-362
14. Ji RR, Schlaepfer TE, Aizenman CD, Epstein CM, Qiu D, Huang JC, Rupp F. Repetitive transcranial magnetic stimulation activates specific regions in rat brain. Proc Natl Acad Sci USA. 1998; 95: 15635-15640
15. Kole MH, Fuchs E, Ziemann U, Paulus W, Ebert U. Changes in 5-HT1A and NMDA binding sites by a single rapid transcranial magnetic stimulation procedure in rats. Brain Res 1999; 826: 309-312
16. Lydiard RB, Steiner M, Burnham D, Gergel I. Efficacy studies of paroxetine in panic disorder. Psychopharmacol Bull 1998; 34: 175-182
17. Marshall RD, Schneier FR, Fallon BA, Knight CB, Abbate LA, Goetz D, Campeas R, Liebowitz MR. An open trial of paroxetine in patients with noncombat-related, chronic posttraumatic stress disorder. J Clin Psychopharmacol 1998; 18: 10-18
18. Martin JD, George MS, Greenberg BD, Wassermann EM, Schlaepfer TE, Murphy DL, Hallette M, Post RM. Mood effects of prefrontal repetitive high frequency transcranial magnetic stimulation in healthy volunteers. CNS Spectrum 1997; 2: 53-68
19. McCann UD, Kimbrell TA, Morgan CM, Anderson T, Geraci M, Benson BE, Wassermann EM, Willis MW, Post RM. Repetitive transcranial magnetic stimulation for posttraumatic stress disorder. Arch Gen Psychiatry 1998; 55: 276-279
20. Pascual-Leone A, Rubio B, Pallardo F, Catala MD. Rapid-rate transcranial magnetic stimulation of left dorsolateral prefrontal cortex in drug-resistant depression. Lancet 1996; 348: 233-237
21. Perrault G, Morel E, Zivkovic B, Sanger DJ. Activity of litoxetine and other serotonin uptake inhibitors in the tail suspension test in mice. Pharmacol Biochem Behav 1992; 42: 45-47
22. Pigott TA, Seay SM. A review of the efficacy of selective serotonin reuptake inhibitors in obsessive-compulsive disorder. J Clin Psychiatry 1999; 60: 101-106
23. Shimada A, Yamaguchi K, Naito H, Narita H, Nishioka Y. Influence of paroxetine on aggressive behavior in raphe-lesioned or olfactorybulbectomized rats. Preclin Rep Cent Inst Exp Amim 1996; 20: 163-167
24. Tulloch IF, Johnson AM. The pharmacologic profile of paroxetine, a new selective serotonin reuptake inhibitor. J Clin Psychiatry 1992; 53 Suppl: 7-12